Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor

The recent 2014–2016 West African Ebola virus epidemic underscores the need for the development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus infections and the lack of FDA-approved vaccine or therapy that is available for the prevention and treatment. Traditional...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Qinghua, Du, Ruikun, Anantpadma, Manu, Schafer, Adam, Hou, Lin, Tian, Jingzhen, Davey, Robert A., Cheng, Han, Rong, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923446/
https://www.ncbi.nlm.nih.gov/pubmed/29584652
http://dx.doi.org/10.3390/v10040152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923446/
https://www.ncbi.nlm.nih.gov/pubmed/29584652
http://dx.doi.org/10.3390/v10040152

Ejemplares similares